1. Kuchler, H.: Amgen, Novartis abandon two alzheimer’s drug studies, https://www.ft.com/content/464ecd76-a41f-11e9-974c-ad1c6ab5efd1 (2019)
2. BBC News: Pharma giant ending alzheimer’s research, https://www.bbc.com/news/health-42633871 (2018)
3. Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S.G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., Cooper, C., Fox, N., Gitlin, L.N., Howard, R., Kales, H.C., Larson, E.B., Ritchie, K., Rockwood, K., Sampson, E.L., Samus, Q., Schneider, L.S., Selbæk, G., Teri, L., Mukadam, N.: Dementia prevention, intervention, and care. The Lancet. 390, 2673–2734 (2017)
4. Hendriks, N., Slegers, K., Wilkinson, A.: Lessons learned from participatory design in dementia care: placing care partners at the centre. In: Kanstrup, A.M., Bygholm, A., Bertelsen, P., Nøhr, C. (eds.) Participatory Design & Health Information Technology, pp. 63–77 (2017)
5. Hassenzahl, M.: The thing and I (Summer of ’17 Remix). In: Funology 2, pp. 17–31. Springer, Cham, Cham (2018)